Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis

Genes and Immunity

Volumn 11, Issue 3, 2010, Pages 269-278

  Reynier, F ^a   Pachot, A ^a   Paye, M ^a   Xu, Q ^b   Turrel Davin, F ^a   Petit, F ^a   Hot, A ^a   Auffray, C ^c   Bendelac, N ^d   Nicolino, M ^d,e   Mougin, B ^a   Thivolet, C ^a,e  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b FUDAN UNIVERSITY   (China)

^c CNRS Institute of Biological Sciences   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

Gene expression; Microarray; Type I diabetes; Type I IFN signature

Indexed keywords

INTERFERON;

ADOLESCENT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OXIDATIVE PHOSPHORYLATION; PEDIGREE ANALYSIS; PRIORITY JOURNAL; TRANSCRIPTOMICS;

ADOLESCENT; CHILD; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77951499602     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2009.112     Document Type: Article

References (48)

1. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994; 15: 516-542.
2. Bach JF. Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation. J Autoimmun 1995; 8: 439-463.
3. Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 1999; 5: 601-604.
4. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 2005; 48: 2221-2228.
5. Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJ, Bingley PJ et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 2004; 53: 384-392.
6. Bingley PJ, Gale EA. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European nicotinamide diabetes intervention trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia 2006; 49: 881-890.
7. Wang X, Jia S, Geoffrey R, Alemzadeh R, Ghosh S, Hessner MJ. Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol 2008; 180: 1929-1937.
8. Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 2007; 92: 3705-3711.
9. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 2006; 147: 126-132.
10. Maas K, Chan S, Parker J, Slater A, Moore J, Olsen N et al. Cutting edge: molecular portrait of human autoimmune disease. J Immunol 2002; 169: 5-9.
11. Batliwalla FM, Li W, Ritchlin CT, Xiao X, Brenner M, Laragione T et al. Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol Med 2005; 11: 21-29.
12. Li D, Butt A, Clarke S, Swaminathana R. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects. Ann N Y Acad Sci 2004; 1022: 147-151. (Pubitemid 38951596)
13. Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, Monneret G. Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett 2006; 106: 63-71.
14. Thach DC, Lin B, Walter E, Kruzelock R, Rowley RK, Tibbetts C et al. Assessment of two methods for handling blood in collection tubes with RNA stabilizing agent for surveillance of gene expression profiles with high density microarrays. J Immunol Methods 2003; 283: 269-279.
15. Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, Schram J et al. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002; 48: 1883-1890.
16. Hartel C, Bein G, Muller-Steinhardt M, Kluter H. Ex vivo induction of cytokine mRNA expression in human blood samples. J Immunol Methods 2001; 249: 63-71.
17. Baccala R, Kono DH, Theofilopoulos AN. Interferons as pathogenic effectors in autoimmunity. Immunol Rev 2005; 204: 9-26.
18. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610-2615.
19. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005; 52: 1491-1503.
20. Baechler EC, Bauer JW, Slattery CA, Ortmann WA, Espe KJ, Novitzke J et al. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med 2007; 13: 59-68.
21. Tan FK, Zhou X, Mayes MD, Gourh P, Guo X, Marcum C et al. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) 2006; 45: 694-702.
22. van Baarsen LG, van der Pouw Kraan TC, Kragt JJ, Baggen JM, Rustenburg F, Hooper T et al. A subtype of multiple sclerosis defined by an activated immune defense program. Genes Immun 2006; 7: 522-531.
23. van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Voskuyl AE, Rustenburg F, Baggen JM et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 2007; 66: 1008-1014.
24. Li Q, Xu B, Michie SA, Rubins KH, Schreriber RD, McDevitt HO. Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci USA 2008; 105: 12439-12444.
25. Huang X, Yuang J, Goddard A, Foulis A, James RF, Lernmark A et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 1995; 44: 658-664.
26. Foulis AK, Farquharson MA, Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 1987; 2: 1423-1427.
27. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540-1543.
28. Wallace J, Petri M, Olsen N, Kirou K, Dennis G, Yao Y et al. Abstract 1315: MEDI-545, an anti-interferon alpha monoclonal antibody, shows evidence of clinical activity in systemic lupus erythematosus (ACR 71st annual scientific meeting). Arthritis Rheum 2007; 56(9 suppl): S526.
29. Lang KS, Weigert C, Braedel S, Fillon S, Palmada M, Schleicher E et al. Inhibition of interferon-gamma expression by osmotic shrinkage of peripheral blood lymphocytes. Am J Physiol Cell Physiol 2003; 284: 200-208.
30. Yeshao W, Gu J, Peng X, Nairn AC, Nadler JL. Elevated glucose activates protein synthesis in cultured cardiac myocytes. Metabolism 2005; 54: 1453-1460.
31. Yin Z, Wilson S, Hauser NC, Tournu H, Hoheisel JD, Brown AJ. Glucose triggers different global responses in yeast, depending on the strength of the signal, and transiently stabilizes ribosomal protein mRNAs. Mol Microbiol 2003; 48: 713-724.
32. Nair KS, Halliday D, Garrow JS. Increased energy expenditure in poorly controlled type 1 (insulin-dependent) diabetic patients. Diabetologia 1984; 27: 13-16.
33. Charlton MR, Nair KS. Role of hyperglucagonemia in catabolism associated with type 1 diabetes: effects on leucine metabolism and the resting metabolic rate. Diabetes 1998; 47: 1748-1756.
34. Peakman M, Tree TI, Endl J, van Endert P, Atkinson MA, Roep BO. Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the second international immunology of diabetes society workshop for standardization of T-cell assays in type 1 diabetes. Diabetes 2001; 50: 1749-1754.
35. van Halteren AG, Kardol MJ, Mulder A, Roep BO. Homing of human autoreactive Tcells into pancreatic tissue of NOD-scid mice. Diabetologia 2005; 48: 75-82.
36. Monks SA, Leonardson A, Zhu H, Cundiff P, Pietrusiak P, Edwards S et al. Genetic inheritance of gene expression in human cell lines. Am J Hum Genet 2004; 75: 1094-1105.
37. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS et al. Genetic analysis of genome-wide variation in human gene expression. Nature 2004; 430: 743-747.
38. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006; 7: 3.
39. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-264.
40. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185-193.
41. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121.
42. Lee ML, Whitmore GA. Power and sample size for DNA microarray studies. Stat Med 2002; 21: 3543-3570.
43. Valentini G. Clusterv: a tool for assessing the reliability of clusters discovered in DNA microarray data. Bioinformatics 2006; 22: 369-370. (Pubitemid 43205390)
44. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3.
45. Hosack DA, Dennis Jr G, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003; 4: R70.
46. Huang da W, Sherman BT, Tan Q, Kir J, Liu D, Bryant D et al. DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007; 35 (Web Server issue): W169-W175.
47. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ et al. A network-based analysis of systemic inflammation in humans. Nature 2005; 437: 1032-1037.
48. Pachot A, Blond JL, Mougin B, Miossec P. Peptidylpropyl isomerase B (PPIB): a suitable reference gene for mRNA quantification in peripheral whole blood. J Biotechnol 2004; 114: 121-124.